Keyes Jeffry R. — SEC Form 4 filings
SEC reporting owner CIK 1557736. 14 Form 4 filings on record with FilingPulse; latest filed 2026-06-24.
Transaction summary — filings shown
Covers all 14 filings on record, filed 2024-03-06 to 2026-06-24. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 2 legs across 2 filings — 100,000 shares, $123,965 total (shares × price as filed).
- Open-market sales (code S, non-derivative): 11 legs across 7 filings — 125,274 shares, $139,430 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 7.
- Largest priced transaction: purchase of 50,000 shares @ $1.61 ($80,500) in Quantum-Si Inc, filed 2024-03-06.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Quantum-Si Inc (QSI) | Chief Financial Officer | 12 | 2 legs · 100,000 sh · $123,965 | 11 legs · 125,274 sh · $139,430 | 4 |
| CNS Pharmaceuticals, Inc. (CNSP) | Director | 2 | — | — | 3 |
Form 4 filings — Keyes Jeffry R.
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-06-24 | 4 | Quantum-Si Inc (QSI) | Sale (S): 4,116 @ $0.96 · Sale (S): 4,117 @ $0.90 | EDGAR |
| 2026-04-22 | 4 | Quantum-Si Inc (QSI) | Sale (S): 37,382 @ $1.01 · Sale (S): 37,381 @ $0.99 | EDGAR |
| 2026-03-24 | 4 | Quantum-Si Inc (QSI) | Sale (S): 4,233 @ $0.85 · Sale (S): 4,422 @ $0.83 | EDGAR |
| 2026-03-16 | 4 | Quantum-Si Inc (QSI) | Grant/award (A): 652,803 @ $0 · Grant/award (A): 780,847 (derivative) @ $0 | EDGAR |
| 2025-12-22 | 4 | Quantum-Si Inc (QSI) | Sale (S): 8,627 @ $1.28 | EDGAR |
| 2025-11-19 | 4 | CNS Pharmaceuticals, Inc. (CNSP) | Grant/award (A): 1,517 (derivative) @ $0 | EDGAR |
| 2025-09-24 | 4 | Quantum-Si Inc (QSI) | Sale (S): 3,873 @ $1.68 · Sale (S): 3,873 @ $1.64 | EDGAR |
| 2025-06-24 | 4 | Quantum-Si Inc (QSI) | Sale (S): 8,624 @ $1.61 | EDGAR |
| 2025-03-24 | 4 | Quantum-Si Inc (QSI) | Sale (S): 8,626 @ $1.39 | EDGAR |
| 2025-03-14 | 4 | Quantum-Si Inc (QSI) | Grant/award (A): 750,000 @ $0 | EDGAR |
| 2024-08-13 | 4 | Quantum-Si Inc (QSI) | Purchase (P): 50,000 @ $0.87 | EDGAR |
| 2024-04-10 | 4 | CNS Pharmaceuticals, Inc. (CNSP) | Grant/award (A): 17,500 (derivative) · Grant/award (A): 17,500 (derivative) | EDGAR |
| 2024-03-18 | 4 | Quantum-Si Inc (QSI) | Grant/award (A): 346,820 @ $0 | EDGAR |
| 2024-03-06 | 4 | Quantum-Si Inc (QSI) | Purchase (P): 50,000 @ $1.61 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1557736 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →